MX2024011270A - Vacunas vivas contra mycoplasma gallisepticum. - Google Patents

Vacunas vivas contra mycoplasma gallisepticum.

Info

Publication number
MX2024011270A
MX2024011270A MX2024011270A MX2024011270A MX2024011270A MX 2024011270 A MX2024011270 A MX 2024011270A MX 2024011270 A MX2024011270 A MX 2024011270A MX 2024011270 A MX2024011270 A MX 2024011270A MX 2024011270 A MX2024011270 A MX 2024011270A
Authority
MX
Mexico
Prior art keywords
mycoplasma gallisepticum
vaccines
live mycoplasma
birds
deposited
Prior art date
Application number
MX2024011270A
Other languages
English (en)
Spanish (es)
Inventor
Naola M Ferguson-Noel
Original Assignee
Univ Georgia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia filed Critical Univ Georgia
Publication of MX2024011270A publication Critical patent/MX2024011270A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/35—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
MX2024011270A 2022-04-06 2023-04-05 Vacunas vivas contra mycoplasma gallisepticum. MX2024011270A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263327851P 2022-04-06 2022-04-06
US202263404226P 2022-09-07 2022-09-07
PCT/US2023/017527 WO2023196374A1 (en) 2022-04-06 2023-04-05 Live mycoplasma gallisepticum vaccines

Publications (1)

Publication Number Publication Date
MX2024011270A true MX2024011270A (es) 2024-09-25

Family

ID=88243428

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024011270A MX2024011270A (es) 2022-04-06 2023-04-05 Vacunas vivas contra mycoplasma gallisepticum.

Country Status (7)

Country Link
US (1) US20250235521A1 (https=)
EP (1) EP4504902A4 (https=)
JP (1) JP2025510684A (https=)
CN (1) CN119816588A (https=)
AU (1) AU2023249151A1 (https=)
MX (1) MX2024011270A (https=)
WO (1) WO2023196374A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117434281B (zh) * 2023-10-18 2026-01-06 上海太阳生物技术有限公司 组合物、检测试剂、检测试剂盒以及在制备检测凝血因子x活性中的应用
CN118078972B (zh) * 2024-03-07 2024-10-22 佛山大学 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用
CN117965308B (zh) * 2024-03-07 2024-09-13 佛山科学技术学院 一种鹅源鸡毒支原体及其分离、鉴定方法和应用
CN119552994B (zh) * 2025-01-17 2025-11-14 广西壮族自治区动物疫病预防控制中心(广西壮族自治区屠宰技术中心) 鉴别鸡毒支原体野毒株和疫苗株的四重荧光pcr引物探针组合、反应体系、方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020187162A1 (en) * 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
US7217420B2 (en) * 2002-07-13 2007-05-15 The University Of Georgia Research Foundation, Inc. Mycoplasma gallisepticum formulation
MX2011007732A (es) * 2009-01-22 2011-11-04 Univ Georgia Formulacion de mycoplasma gallisepticum.
EP3391903B1 (en) * 2017-04-21 2022-02-23 The Pirbright Institute Recombinant gallid herpesvirus 3 vaccines encoding heterologous avian pathogen antigens

Also Published As

Publication number Publication date
US20250235521A1 (en) 2025-07-24
WO2023196374A1 (en) 2023-10-12
EP4504902A4 (en) 2026-05-06
EP4504902A1 (en) 2025-02-12
AU2023249151A1 (en) 2024-09-19
JP2025510684A (ja) 2025-04-15
CN119816588A (zh) 2025-04-11

Similar Documents

Publication Publication Date Title
MX2024011270A (es) Vacunas vivas contra mycoplasma gallisepticum.
CO2019012893A2 (es) Composiciones farmacéuticas de atropina
CO2018005361A2 (es) Formulaciones inyectables de toxina botulínica y sus métodos de uso que poseen efecto terapéutico o cosmético de larga duración
PE20190451A1 (es) Composiciones que comprenden cepas bacterianas
UY36422A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
AR069216A1 (es) Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos
MX2015005148A (es) Formas il-15r alfa, celulas que expresan las formas de il-15 alfa, y usos terapeuticos de il-15r alfa y complejos il-15/il-15r.
CO2020000328A2 (es) Formulaciones a largo plazo
AR101674A1 (es) Uso de un compuesto tricíclico que contiene nitrógeno
CO2020005919A2 (es) Compuestos y composiciones farmaceuticas de los mismos para usarse en el tratamiento de enfermedades fibroticas
BR112023000220A2 (pt) Formulações de longa ação
BR112021024651A2 (pt) Composição farmacêutica parenteral isotônica, método para melhoria da estabilidade química da dita composição e uso de manitol ou um sal
MX390536B (es) Composicion farmaceutica topica que comprende al menos amitriptilina para el tratamiento del dolor neuropatico periferico.
CO2019004004A2 (es) Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico
MX2021008017A (es) Formulaciones de colagenasa y metodos de produccion de las mismas.
MX2016016885A (es) Administracion in ovo de cultivos probioticos.
AR114418A1 (es) Compuesto cíclico de metilactama y su utilización farmacéutica
BR112023005001A2 (pt) Isolado atenuado do vírus da estirpe dmv1639 de bronquite infecciosa
AR128777A1 (es) Vacuna viva contra mycoplasma synoviae
WO2010085611A3 (en) Mycoplasma gallisepticum formulation
CL2018002705A1 (es) Glucono delta-lactona para el tratamiento de infecciones fúngicas vaginales
BR112022010687A2 (pt) Cepas de reovírus aviário atenuado 94826 c140 e 96139 c140
AR128986A1 (es) Vacuna viva contra mycoplasma gallisepticum
EA201890929A1 (ru) Низкие дозировки композиций дипиридамола для перорального приема и их использование
UY38473A (es) Formulaciones farmacéuticas para una administración subcutánea